首页> 美国卫生研究院文献>Pharmacy: Journal of Pharmacy Education and Practice >The Effectiveness of Nonprescription Drug Labels in the United States: Insights from Recent Research and Opportunities for the Future
【2h】

The Effectiveness of Nonprescription Drug Labels in the United States: Insights from Recent Research and Opportunities for the Future

机译:非处方药标签在美国的有效性:最新研究的启示和未来的机遇

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite providing a consistent and comprehensible format for over-the-counter (OTC) drug communication, research suggests important limitations in the communication effectiveness of the Drug Facts Label required on OTC drugs in the United States. This literature is reviewed and some of these critical limitations of the Drug Facts Label (DFL) highlighted. These include difficulty communicating complex information that requires integration of multiple pieces of label information and limited adaptability to serve the unique needs of individual populations (e.g., low literacy or older consumers). Potential ways to improve the DFL’s communication effectiveness are identified along with complementary opportunities to improve OTC drug communication by leveraging the role of pharmacists and use of adjunctive technologies.
机译:尽管为非处方药(OTC)提供了一致且可理解的格式,但研究表明,在美国,OTC​​药品所需的《药品概况》标签的沟通有效性受到了重要限制。回顾了这些文献,并强调了《药物事实标签》(DFL)的一些关键局限性。其中包括难以传达复杂的信息,而复杂的信息需要整合多个标签信息,并且适应性有限,无法满足个别人群(例如识字率较低或年龄较大的消费者)的独特需求。通过利用药剂师的角色和辅助技术的使用,确定了提高DFL沟通效率的潜在方法以及改善OTC药品沟通的补充机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号